Literature DB >> 15333649

Demystified...recombinant antibodies.

K A Smith1, P N Nelson, P Warren, S J Astley, P G Murray, J Greenman.   

Abstract

Recombinant antibodies are important tools for biomedical research and are increasingly being used as clinical diagnostic/therapeutic reagents. In this article, a background to humanized antibodies is given, together with details of the generation of antibody fragments--for example, single chain Fv fragments. Phage antibody fragments are fast becoming popular and can be generated by simple established methods of affinity enrichment from libraries derived from immune cells. Phage display methodology can also be used for the affinity enrichment of existing antibody fragments to provide a reagent with a higher affinity. Here, phage antibodies are demystified to provide a greater understanding of the potential of these reagents and to engage clinicians and biomedical scientists alike to think about potential applications in pathology and clinical settings.

Mesh:

Substances:

Year:  2004        PMID: 15333649      PMCID: PMC1770420          DOI: 10.1136/jcp.2003.014407

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  46 in total

1.  Isolation of Acanthamoeba-specific antibodies from a bacteriophage display library.

Authors:  N A Khan; J Greenman; K P Topping; V C Hough; G S Temple; T A Paget
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  A human myeloma cell line suitable for the generation of human monoclonal antibodies.

Authors:  A Karpas; A Dremucheva; B H Czepulkowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 3.  Monoclonal antibodies.

Authors:  P N Nelson; G M Reynolds; E E Waldron; E Ward; K Giannopoulos; P G Murray
Journal:  Mol Pathol       Date:  2000-06

Review 4.  Antibody engineering at the millennium.

Authors:  J V Gavilondo; J W Larrick
Journal:  Biotechniques       Date:  2000-07       Impact factor: 1.993

Review 5.  Natural and designer binding sites made by phage display technology.

Authors:  H R Hoogenboom; P Chames
Journal:  Immunol Today       Date:  2000-08

6.  In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.

Authors:  N Kang; S Hamilton; J Odili; G Wilson; J Kupsch
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

Review 7.  Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer.

Authors:  K A Chester; A Mayer; J Bhatia; L Robson; D I Spencer; S P Cooke; A A Flynn; S K Sharma; G Boxer; R B Pedley; R H Begent
Journal:  Cancer Chemother Pharmacol       Date:  2000       Impact factor: 3.333

8.  A3--a novel colon and pancreatic cancer reactive antibody from a primate phage library selected using intact tumour cells.

Authors:  J Tordsson; S Lavasani; L Ohlsson; P Karlström; H Svedberg; L Abrahmsén; T Brodin
Journal:  Int J Cancer       Date:  2000-08-15       Impact factor: 7.396

9.  Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth factor.

Authors:  A Vitaliti; M Wittmer; R Steiner; L Wyder; D Neri; R Klemenz
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

10.  Immunological properties of a single-chain fragment of the anti-idiotypic antibody ACA125.

Authors:  S Reinartz; U Wagner; P Giffels; U Gruenn; H Schlebusch; D Wallwiener
Journal:  Cancer Immunol Immunother       Date:  2000-07       Impact factor: 6.968

View more
  10 in total

1.  Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2.

Authors:  Elisabeth Ravaoarisoa; Halima Zamanka; Thierry Fusai; Jacques Bellalou; Hugues Bedouelle; Odile Mercereau-Puijalon; Thierry Fandeur
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 2.  Structure and function of immunoglobulins.

Authors:  Harry W Schroeder; Lisa Cavacini
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

Review 3.  Molecular imaging with nanoparticles: giant roles for dwarf actors.

Authors:  Paul Debbage; Werner Jaschke
Journal:  Histochem Cell Biol       Date:  2008-09-30       Impact factor: 4.304

4.  Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

Authors:  Jan David Hohmann; Xiaowei Wang; Stefanie Krajewski; Carly Selan; Carolyn A Haller; Andreas Straub; Elliot L Chaikof; Harshal H Nandurkar; Christoph E Hagemeyer; Karlheinz Peter
Journal:  Blood       Date:  2013-02-04       Impact factor: 22.113

5.  Age- and Sex-associated Differences in Phenotypic and Functional Characteristics of Peripheral Blood Lymphocytes in Chimpanzees (Pan troglodytes).

Authors:  Pramod N Nehete; Elizabeth R Magden; Bharti P Nehete; Lawrence E Williams; Christian R Abee; K Jagannadha Sastry
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

6.  Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer.

Authors:  Chrysovalanto Staneloudi; Karen A Smith; Robert Hudson; Nela Malatesti; Huguette Savoie; Ross W Boyle; John Greenman
Journal:  Immunology       Date:  2007-04       Impact factor: 7.397

Review 7.  Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions.

Authors:  Rajan Saini; Nathan V Lee; Kelly Y P Liu; Catherine F Poh
Journal:  Cancers (Basel)       Date:  2016-09-02       Impact factor: 6.639

8.  Design and Construction of a Novel Humanized Single-Chain Variable-Fragment Antibody Against the Tumor Necrosis Factor Alpha.

Authors:  Davoud Farajzadeh; Sadigheh Karimi-Gharigh; Parisa Jalali-Kondori; Siavoush Dastmalchi
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

9.  Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.

Authors:  Anjeanette Roberts; William D Thomas; Jeannette Guarner; Elaine W Lamirande; Gregory J Babcock; Thomas C Greenough; Leatrice Vogel; Norman Hayes; John L Sullivan; Sherif Zaki; Kanta Subbarao; Donna M Ambrosino
Journal:  J Infect Dis       Date:  2006-01-27       Impact factor: 5.226

10.  Antibody validation for Western blot: By the user, for the user.

Authors:  Lakshmi Pillai-Kastoori; Sam Heaton; Steve D Shiflett; Annabelle C Roberts; Alejandra Solache; Amy R Schutz-Geschwender
Journal:  J Biol Chem       Date:  2019-12-09       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.